Piramal Pharma Limited (PPLPHARMA.NS) NSE

166.92

-3.98(-2.33%)

Updated at June 02 03:30PM

Currency In INR

Valuation

Market Cap180.91B
Enterprise Value225.42B
P/E Ratio-64.53
PEG Ratio0.65
Price/Sales Ratio2.49
Price/Book Ratio2.58
Enterprise/Revenue3
Enterprise/EBITDA24.21

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.04
Operating Margin0.01

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue88.69B
Revenue/Share70.39
Gross Profit23.83B
EBITDA9.22B
Net Income-3.26B
Diluted EPS-2.46

Balance Sheet

Total Cash13.55B
Total Cash/Share10.76
Total Debt56.75B
Total Debt/Equity0.7
Current Ratio1.51
Book Value Per Share64.78

Price History

52-Week Change-18.84
52-Week High220.85
52-Week Low132.3
Moving Average 50 Days159.56
Moving Average 200 Days173.44

Statistics

Average Volume5.39M
Shares Outstanding1.32B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.14
Trailing Annual Dividend Yield0.08
Payout Ratio-0.06
Last Split Factor1023:1000
Last Split DateAugust 02, 2023